March 09, 2018
Trump Is the Peacemaker Korea Has Always Needed
Coming against all odds, enduring withering criticism, and facing deep cynicism, Donald Trump announced his decision to become the first sitting American president to meet North Korea’s supreme leader. The Kim family regime invited previous U.S. presidents to meet, but Trump’s swift acceptance of Kim Jong Un’s invitation is a bold gamble that seizes an opportunity produced by a hard-edged pressure strategy. Assuming it takes place by May, the summit is also made possible by Kim’s recent burst of diplomatic dexterity. The two leaders are mirroring each other, gambit for gambit.
The Trump administration’s much-maligned North Korea policy always included two countervailing parts, like the positive yin and negative yang forces in the circle of the South Korean flag: engagement and maximum pressure. Before the Olympics, pressure took center stage; now it appears likely that post-Olympics will focus at least for a while more on engagement and diplomacy.
Read the full article in Foreign Policy.
More from CNAS
-
Podcast
Defense / Indo-Pacific Security
Hellscape Taiwan: Drones, Deterrence, and the Future of Asymmetric DefenseStacie Pettyjohn joined the Irregular Warfare Podcast to examine how Taiwan could deter—or potentially defeat—a Chinese invasion by transforming the Taiwan Strait into an “unm...
By Stacie Pettyjohn
-
Video
Indo-Pacific Security / Energy, Economics & Security
Analysts Break Down Trump-Xi Meeting and Calls for Stability and CooperationFor perspective on President Trump's trip and the broader U.S.-China relationship, Geoff Bennett spoke with Myron Brilliant and Liza Tobin. Brilliant is at the DGA Group and i...
By Liza Tobin
-
Video
Indo-Pacific Security / Energy, Economics & Security
Rajdeep Sardesai Asks Big Question on US-ChinaThe debate on the Big Question, with Daniel Silverberg, adjunct senior fellow at the Center for a New American Security, explores whether Beijing holds the key to resolving th...
By Daniel Silverberg
-
China’s Pharmaceutical Weapon
Commentary
Until SAPIR is extended to biologically derived drugs, until the FDA clears the bovine pathway, and until at least one American-owned heparin manufacturer operates on US soil,...
By Jennifer Hendrixson White
